Last reviewed · How we verify
Advil PM Liqui-Gels Minis
Acetaminophen is a non-selective COX inhibitor.
Acetaminophen is a non-selective COX inhibitor. Used for Relief of mild to moderate pain, Reduction of fever.
At a glance
| Generic name | Advil PM Liqui-Gels Minis |
|---|---|
| Sponsor | HALEON |
| Drug class | NSAID |
| Target | COX |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | Phase 1 |
Mechanism of action
It works by inhibiting the production of prostaglandins, which are mediators of pain and inflammation.
Approved indications
- Relief of mild to moderate pain
- Reduction of fever
Common side effects
- Nausea
- Dizziness
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Advil PM Liqui-Gels Minis CI brief — competitive landscape report
- Advil PM Liqui-Gels Minis updates RSS · CI watch RSS
- HALEON portfolio CI